Overview and discussion of key trends and events in the 2023 ophthalmology marketplace.

Significant financial commitments are required for FDA clearance of new products. As global strategics increasingly delay investment, how can pioneering companies persevere?

With the approval of two new drugs and multiple other pathways under investigation in human trials, new treatments for GA have the potential to revolutionize patient care.